Related Experiment Video

Updated: May 9, 2026

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
09:37

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation

Published on: March 15, 2018

OA-4 inhibits osteoclast formation and bone resorption via suppressing RANKL induced P38 signaling pathway

B Tian, A Qin, Z Y Shao

  • 1Shanghai Key Laboratory of Orthopaedic Implants, Department of Orthopaedics, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, The People's Republic of China, Address: 639 Zhizaoju Road, Shanghai 200011, P.R.China. zhuzhe-nan2006@126.com.

Current Medicinal Chemistry
|July 31, 2013
PubMed

Insights

A novel compound, OA-4, effectively inhibits osteoclast formation and function. This discovery offers a potential new therapeutic strategy for orthopedic diseases like osteoporosis and osteoarthritis.

Area of Science:

  • Biochemistry
  • Orthopedics
  • Pharmacology

Background:

  • Osteoclasts play a critical role in bone metabolism and are implicated in orthopedic diseases.
  • Targeting osteoclast activity is a key strategy for treating conditions like osteoporosis and osteoarthritis.

Purpose of the Study:

  • To synthesize a novel compound, OA-4 (N-(3-(cyclohexylcarbamoyl) phenyl)-1H-indole-2- carboxamide).
  • To investigate the effects of OA-4 on osteoclast differentiation and function.
  • To elucidate the molecular mechanisms underlying OA-4's action.

Main Methods:

  • Synthesis of the novel compound OA-4.
  • Assessment of OA-4's impact on osteoclast differentiation and gene expression.
  • Evaluation of OA-4's effect on osteoclastic bone resorption.
  • Analysis of OA-4's influence on key intracellular signaling pathways (p38, JNK, NF-κB).

Main Results:

  • OA-4 significantly inhibited osteoclast differentiation and specific gene expression in a dose-dependent manner.
  • OA-4 dose-dependently suppressed osteoclastic bone resorption.
  • OA-4 attenuated RANKL-induced p38 phosphorylation but did not affect JNK or NF-κB pathways.

Conclusions:

  • The novel compound OA-4 effectively inhibits osteoclast formation and function.
  • OA-4 exerts its inhibitory effects through the suppression of the p38 signaling pathway.
  • OA-4 represents a promising therapeutic candidate for orthopedic diseases driven by osteoclast activity.

More Related Videos

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro07:03

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro

Published on: June 16, 2022

Related Concept Videos

Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...